Literature DB >> 27294619

Protein-structure-guided discovery of functional mutations across 19 cancer types.

Beifang Niu1, Adam D Scott1,2, Sohini Sengupta1,2, Matthew H Bailey1,2, Prag Batra1, Jie Ning1,3, Matthew A Wyczalkowski1,2, Wen-Wei Liang1,2, Qunyuan Zhang1,4, Michael D McLellan1, Sam Q Sun1,2, Piyush Tripathi3, Carolyn Lou1,2, Kai Ye1,4, R Jay Mashl1,2, John Wallis1, Michael C Wendl1,2,4,5, Feng Chen3,6,7, Li Ding1,2,3,6.   

Abstract

Local concentrations of mutations are well known in human cancers. However, their three-dimensional spatial relationships in the encoded protein have yet to be systematically explored. We developed a computational tool, HotSpot3D, to identify such spatial hotspots (clusters) and to interpret the potential function of variants within them. We applied HotSpot3D to >4,400 TCGA tumors across 19 cancer types, discovering >6,000 intra- and intermolecular clusters, some of which showed tumor and/or tissue specificity. In addition, we identified 369 rare mutations in genes including TP53, PTEN, VHL, EGFR, and FBXW7 and 99 medium-recurrence mutations in genes such as RUNX1, MTOR, CA3, PI3, and PTPN11, all mapping within clusters having potential functional implications. As a proof of concept, we validated our predictions in EGFR using high-throughput phosphorylation data and cell-line-based experimental evaluation. Finally, mutation-drug cluster and network analysis predicted over 800 promising candidates for druggable mutations, raising new possibilities for designing personalized treatments for patients carrying specific mutations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27294619      PMCID: PMC5315576          DOI: 10.1038/ng.3586

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  35 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

3.  Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.

Authors:  Shih-Ching Lo; Xuchu Li; Michael T Henzl; Lesa J Beamer; Mark Hannink
Journal:  EMBO J       Date:  2006-08-03       Impact factor: 11.598

4.  LS-SNP/PDB: annotated non-synonymous SNPs mapped to Protein Data Bank structures.

Authors:  Michael Ryan; Mark Diekhans; Stephanie Lien; Yun Liu; Rachel Karchin
Journal:  Bioinformatics       Date:  2009-04-15       Impact factor: 6.937

5.  Comprehensive assessment of cancer missense mutation clustering in protein structures.

Authors:  Atanas Kamburov; Michael S Lawrence; Paz Polak; Ignaty Leshchiner; Kasper Lage; Todd R Golub; Eric S Lander; Gad Getz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

6.  Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells.

Authors:  R Friesel; W H Burgess; T Maciag
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

7.  Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.

Authors:  Rama Krishna Kancha; Nikolas von Bubnoff; Christian Peschel; Justus Duyster
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

8.  SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.

Authors:  Nicholas I Fleming; Robert N Jorissen; Dmitri Mouradov; Michael Christie; Anuratha Sakthianandeswaren; Michelle Palmieri; Fiona Day; Shan Li; Cary Tsui; Lara Lipton; Jayesh Desai; Ian T Jones; Stephen McLaughlin; Robyn L Ward; Nicholas J Hawkins; Andrew R Ruszkiewicz; James Moore; Hong-Jian Zhu; John M Mariadason; Antony W Burgess; Dana Busam; Qi Zhao; Robert L Strausberg; Peter Gibbs; Oliver M Sieber
Journal:  Cancer Res       Date:  2012-11-08       Impact factor: 12.701

9.  Functional impact bias reveals cancer drivers.

Authors:  Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nucleic Acids Res       Date:  2012-08-16       Impact factor: 16.971

10.  Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).

Authors:  Dario de Biase; Michela Visani; Umberto Malapelle; Francesca Simonato; Valentina Cesari; Claudio Bellevicine; Annalisa Pession; Giancarlo Troncone; Ambrogio Fassina; Giovanni Tallini
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more
  59 in total

1.  PertInInt: An Integrative, Analytical Approach to Rapidly Uncover Cancer Driver Genes with Perturbed Interactions and Functionalities.

Authors:  Shilpa Nadimpalli Kobren; Bernard Chazelle; Mona Singh
Journal:  Cell Syst       Date:  2020-07-14       Impact factor: 10.304

2.  Comparison of algorithms for the detection of cancer drivers at subgene resolution.

Authors:  Eduard Porta-Pardo; Atanas Kamburov; David Tamborero; Tirso Pons; Daniela Grases; Alfonso Valencia; Nuria Lopez-Bigas; Gad Getz; Adam Godzik
Journal:  Nat Methods       Date:  2017-07-17       Impact factor: 28.547

3.  Database of evidence for precision oncology portal.

Authors:  Sam Q Sun; R Jay Mashl; Sohini Sengupta; Adam D Scott; Weihua Wang; Prag Batra; Liang-Bo Wang; Matthew A Wyczalkowski; Li Ding
Journal:  Bioinformatics       Date:  2018-12-15       Impact factor: 6.937

4.  Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment.

Authors:  Weiwei Shan; Jiao Yuan; Zhongyi Hu; Junjie Jiang; Yueying Wang; Nicki Loo; Lingling Fan; Zhaoqing Tang; Tianli Zhang; Mu Xu; Yutian Pan; Jiaqi Lu; Meixiao Long; Janos L Tanyi; Kathleen T Montone; Yi Fan; Xiaowen Hu; Youyou Zhang; Lin Zhang
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

Review 5.  Functional variomics and network perturbation: connecting genotype to phenotype in cancer.

Authors:  Song Yi; Shengda Lin; Yongsheng Li; Wei Zhao; Gordon B Mills; Nidhi Sahni
Journal:  Nat Rev Genet       Date:  2017-03-27       Impact factor: 53.242

6.  PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro.

Authors:  Xiaowen Wu; Jiayi Yu; Junya Yan; Jie Dai; Lu Si; Zhihong Chi; Xinan Sheng; Chuanliang Cui; Meng Ma; Huan Tang; Tianxiao Xu; Huan Yu; Yan Kong; Jun Guo
Journal:  Cancer Biol Ther       Date:  2018-04-30       Impact factor: 4.742

7.  Integrated structural and evolutionary analysis reveals common mechanisms underlying adaptive evolution in mammals.

Authors:  Greg Slodkowicz; Nick Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

8.  Systematic Functional Annotation of Somatic Mutations in Cancer.

Authors:  Patrick Kwok-Shing Ng; Jun Li; Kang Jin Jeong; Shan Shao; Hu Chen; Yiu Huen Tsang; Sohini Sengupta; Zixing Wang; Venkata Hemanjani Bhavana; Richard Tran; Stephanie Soewito; Darlan Conterno Minussi; Daniela Moreno; Kathleen Kong; Turgut Dogruluk; Hengyu Lu; Jianjiong Gao; Collin Tokheim; Daniel Cui Zhou; Amber M Johnson; Jia Zeng; Carman Ka Man Ip; Zhenlin Ju; Matthew Wester; Shuangxing Yu; Yongsheng Li; Christopher P Vellano; Nikolaus Schultz; Rachel Karchin; Li Ding; Yiling Lu; Lydia Wai Ting Cheung; Ken Chen; Kenna R Shaw; Funda Meric-Bernstam; Kenneth L Scott; Song Yi; Nidhi Sahni; Han Liang; Gordon B Mills
Journal:  Cancer Cell       Date:  2018-03-12       Impact factor: 31.743

9.  Proteogenomic Characterization of Endometrial Carcinoma.

Authors:  Yongchao Dou; Emily A Kawaler; Daniel Cui Zhou; Marina A Gritsenko; Chen Huang; Lili Blumenberg; Alla Karpova; Vladislav A Petyuk; Sara R Savage; Shankha Satpathy; Wenke Liu; Yige Wu; Chia-Feng Tsai; Bo Wen; Zhi Li; Song Cao; Jamie Moon; Zhiao Shi; MacIntosh Cornwell; Matthew A Wyczalkowski; Rosalie K Chu; Suhas Vasaikar; Hua Zhou; Qingsong Gao; Ronald J Moore; Kai Li; Sunantha Sethuraman; Matthew E Monroe; Rui Zhao; David Heiman; Karsten Krug; Karl Clauser; Ramani Kothadia; Yosef Maruvka; Alexander R Pico; Amanda E Oliphant; Emily L Hoskins; Samuel L Pugh; Sean J I Beecroft; David W Adams; Jonathan C Jarman; Andy Kong; Hui-Yin Chang; Boris Reva; Yuxing Liao; Dmitry Rykunov; Antonio Colaprico; Xi Steven Chen; Andrzej Czekański; Marcin Jędryka; Rafał Matkowski; Maciej Wiznerowicz; Tara Hiltke; Emily Boja; Christopher R Kinsinger; Mehdi Mesri; Ana I Robles; Henry Rodriguez; David Mutch; Katherine Fuh; Matthew J Ellis; Deborah DeLair; Mathangi Thiagarajan; D R Mani; Gad Getz; Michael Noble; Alexey I Nesvizhskii; Pei Wang; Matthew L Anderson; Douglas A Levine; Richard D Smith; Samuel H Payne; Kelly V Ruggles; Karin D Rodland; Li Ding; Bing Zhang; Tao Liu; David Fenyö
Journal:  Cell       Date:  2020-02-13       Impact factor: 41.582

10.  Comprehensive characterization of protein-protein interactions perturbed by disease mutations.

Authors:  Feixiong Cheng; Junfei Zhao; Yang Wang; Weiqiang Lu; Zehui Liu; Yadi Zhou; William R Martin; Ruisheng Wang; Jin Huang; Tong Hao; Hong Yue; Jing Ma; Yuan Hou; Jessica A Castrillon; Jiansong Fang; Justin D Lathia; Ruth A Keri; Felice C Lightstone; Elliott Marshall Antman; Raul Rabadan; David E Hill; Charis Eng; Marc Vidal; Joseph Loscalzo
Journal:  Nat Genet       Date:  2021-02-08       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.